NCT06868927View on ClinicalTrials.gov

Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform

Not yet recruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Renal Tumors

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER

NCT06868927 - Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform | Biotech Hunter | Biotech Hunter